Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Acetaminophen/Naproxen Sodium FDC in Adolescents with Orthodontic Pain
NCT05844995Phase 1Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of acetaminophen and Aprol in orthodontic pain, sponsored by Johnson & Johnson. Primary endpoints: Apparent Clearance, Apparent Central Volume of Distribution and 9 more. Started Sep 2023; status: completed.
02
Drugs
acetaminophenAprol
03
Conditions
orthodontic pain
Beyond the preview
Go deeper on NCT05844995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844995.